667 related articles for article (PubMed ID: 7693298)
1. Neurochemical substrates of rigidity and chorea in Huntington's disease.
Storey E; Beal MF
Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
[TBL] [Abstract][Full Text] [Related]
2. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia.
Albin RL; Reiner A; Anderson KD; Penney JB; Young AB
Ann Neurol; 1990 Apr; 27(4):357-65. PubMed ID: 1972318
[TBL] [Abstract][Full Text] [Related]
3. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
Glass M; Dragunow M; Faull RL
Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
[TBL] [Abstract][Full Text] [Related]
4. Pallidal GABA and chorea in Huntington's disease.
Pearson SJ; Heathfield KW; Reynolds GP
J Neural Transm Gen Sect; 1990; 81(3):241-6. PubMed ID: 2144428
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
8. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy.
Kanazawa I; Sasaki H; Muramoto O; Matsushita M; Mizutani T; Iwabuchi K; Ikeda T; Takahata N
J Neurol Sci; 1985 Sep; 70(2):151-65. PubMed ID: 2865338
[TBL] [Abstract][Full Text] [Related]
9. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
[TBL] [Abstract][Full Text] [Related]
10. A detailed examination of substance P in pathologically graded cases of Huntington's disease.
Beal MF; Ellison DW; Mazurek MF; Swartz KJ; Malloy JR; Bird ED; Martin JB
J Neurol Sci; 1988 Mar; 84(1):51-61. PubMed ID: 2452859
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
Alberch J; Pérez-Navarro E; Canals JM
Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
[TBL] [Abstract][Full Text] [Related]
12. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
Fenney A; Jog MS; Duval C
Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
[TBL] [Abstract][Full Text] [Related]
13. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
Bird ED; Iversen LL
Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
[No Abstract] [Full Text] [Related]
14. The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain.
Waldvogel HJ; Faull RL
Adv Pharmacol; 2015; 73():223-64. PubMed ID: 25637443
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical findings in Huntington's chorea.
Bird ED; Iversen LL
Essays Neurochem Neuropharmacol; 1977; 1():177-95. PubMed ID: 152197
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
[TBL] [Abstract][Full Text] [Related]
17. Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.
Morton AJ; Nicholson LF; Faull RL
Neuroscience; 1993 Mar; 53(1):159-68. PubMed ID: 7682296
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
Spokes EG
Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
[TBL] [Abstract][Full Text] [Related]
19. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea.
Crossman AR; Mitchell IJ; Sambrook MA; Jackson A
Brain; 1988 Oct; 111 ( Pt 5)():1211-33. PubMed ID: 3179691
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
Grafe MR; Forno LS; Eng LF
J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
